References
- Mittal G Kumar NMVR . Impact of polymeric nanoparticles on oral pharmacokinetics: a dose-dependent case study with estradiol. J. Pharm. Sci.98, 3730–3734 (2009).
- George JK Singh SK Verma PRP . Morphological and in vitro investigation of core–shell nanostructures of carvedilol using quality by design. J. Pharm. Investig.45, 561–578 (2015).
- Ubrich N Schmidt C Bodmeier R et al. Oral evaluation in rabbits of cyclosporin-loaded Eudragit RS or RL nanoparticles. Int. J. Pharm.288, 169–75 (2005).
- Schaffazick SR Siqueira IR Badejo AS et al. Incorporation in polymeric nanocapsules improves the antioxidant effect of melatonin against lipid peroxidation in mice brain and liver. Eur. J. Pharm. Biopharm.69, 64–71 (2008).
- Plapied L Duhem N des Rieux A et al. Fate of polymeric nanocarriers for oral drug delivery. Curr. Opin. Colloid Interface Sci.16, 228–237 (2011).
- Ferranti V Marchais H Chabenat C et al. Primidone-loaded poly-ε-caprolactone nanocapsules: incorporation efficiency and in vitro release profiles. Int. J. Pharm.193, 107–111 (1999).
- Alanazi FK Haq N Radwan AA et al. Potential of lipid nanoemulsion for drug delivery of cholesteryl-hexahydrophthaloyl-5-fluorouracil. J. Drug Deliv. Sci. Technol.24, 459–463 (2014).
- Steiner JF . Clinical pharmacokinetics and pharmacodynamics of finasteride. Clin. Pharmacokinet.30, 16–27 (1996).
- Bhagat C Singh SK Verma PRP et al. Crystalline and amorphous carvedilol-loaded nanoemulsions: formulation optimisation using response surface methodology. J. Exp. Nanosci.8, 971–992 (2013).
- Singh SK Verma PRP Razdan B . Development and characterization of a carvedilol-loaded self-microemulsifying delivery system. Clin. Res. Regul. Aff.26, 50–64 (2009).
- Saini R Singh SK Verma PRP . Evaluation of carvedilol-loaded microsponges with nanometric pores using response surface methodology. J. Exp. Nanosci.9, 831–850 (2012).
- Wang Y-J Wu Y-T Lin J-Y et al. Rapid quantitative analysis of clarithromycin in rat plasma by UPLC–MS/MS after intravenous injection of the clarithromycin-loaded ultrafine PLGA nanoparticles. J. Chromatogr. B.895–896, 178–181 (2012).
- Pitt JJ . Principles and applications of liquid chromatography–mass spectrometry in clinical biochemistry. Clin. Biochem. Rev.30, 19–34 (2009).
- Grbic S Parojcic J Ibric S et al. In vitro–in vivo correlation for gliclazide immediate-release tablets based on mechanistic absorption simulation. AAPS PharmSciTech12, 165–171 (2011).
- Wu C Kou L Ma P et al. Interspecies prediction of oral pharmacokinetics of different lacidipine formulations from dogs to human: physiologically based pharmacokinetic modelling combined with biorelevant dissolution. RSC Adv.5, 19844–19852 (2015).
- Hendriksen B Felix MVS Bolger MB . The composite solubility versus pH profile and its role in intestinal absorption prediction. AAPS PharmSci.5, 35–49 (2003).
- US Food and Drug Administration . Guidance for industry: extended release oral dosage forms: development, evaluation, and application of in vitro/in vivo correlations. September 1997.
- Mirza T Bykadi SA Ellison CD et al. Use of in vitro–in vivo correlation to predict the pharmacokinetics of several products containing a BCS Class 1 drug in extended release matrices. Pharm. Res.30, 179–190 (2013).
- Fessi H Puisieux F Devissaguet JP et al. Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int. J. Pharm.55, R1–R4 (1989).
- Hayes S Dunne A Smart T et al. Interpretation and optimization of the dissolution specifications for a modified release product with an in vivo–in vitro correlation (IVIVC). J. Pharm. Sci.93, 571–81 (2004).
- Nishioka Y Yoshino H . Lymphatic targeting with nanoparticulate system. Adv. Drug Deliv. Rev.47, 55–64 (2001).
- Kim YI Fluckiger L Hoffman M et al. The antihypertensive effect of orally administered nifedipine-loaded nanoparticles in spontaneously hypertensive rats. Br. J. Pharmacol.120, 399–404 (1997).
- Singh B Singh R Bandyopadhyay S et al. Optimized nanoemulsifying systems with enhanced bioavailability of carvedilol. Colloids Surf. B. Biointerfaces101, 465–474 (2013).
- Venishetty VK Chede R Komuravelli R et al. Design and evaluation of polymer coated carvedilol loaded solid lipid nanoparticles to improve the oral bioavailability: a novel strategy to avoid intraduodenal administration. Colloids Surf. B. Biointerfaces95, 1–9 (2012).
- Jiao Y Ubrich N Marchand-Arvier M et al. In vitro and in vivo evaluation of oral heparin−loaded polymeric nanoparticles in rabbits. Circulation.105, 230–235 (2002).
- Nolte K Backfisch G Neidlein R . In vitro absorption studies with carvedilol using a new model with porcine intestine called BM-RIMO (Boehringer–Mannheim ring model). Arzneimittelforschung.49, 745–749 (1999).
- Liu D Pan H He F et al. Effect of particle size on oral absorption of carvedilol nanosuspensions: in vitro and in vivo evaluation. Int. J. Nanomed.10, 6425–6434 (2015).
- Tilney NL . Patterns of lymphatic drainage in the adult laboratory rat. J. Anat.109, 369–383 (1971).
- Honório TS Pinto EC Rocha HVA et al. In vitro–in vivo correlation of efavirenz tablets using GastroPlus®. AAPS PharmSciTech14, 1244–1254 (2013).
- Loftsson T Vogensen SB Desbos C et al. Carvedilol: solubilization and cyclodextrin complexation: a technical note. AAPS Pharm. Sci. Tech.9, 425–430 (2008).